CNBX Pharmaceuticals Inc. (CNBX)
OTCMKTS: CNBX · Delayed Price · USD
0.0159
+0.0019 (13.57%)
Mar 28, 2024, 3:49 PM EDT - Market closed

CNBX Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Sep - Aug.
Year 2023202220212020201920182017201620152014 2013 - 2005
Net Income
-3.71-3.77-2.49-3.111.13-3.78-1.93-0.31-0.54-0.27
Upgrade
Depreciation & Amortization
0.160.20.220.220.190.090.01000
Upgrade
Share-Based Compensation
0.180.730.030.070.25000-0.080
Upgrade
Other Operating Activities
3.261.16-0.260.05-4.661.711.060.190.440.07
Upgrade
Operating Cash Flow
-0.11-1.68-2.49-2.77-3.09-1.97-0.86-0.12-0.18-0.2
Upgrade
Capital Expenditures
0-0-0-0.08-0.22-0.94-0.130-0-0.03
Upgrade
Acquisitions
00.03005.2500000
Upgrade
Change in Investments
-0.02--0.65-3.36-3.11-----
Upgrade
Other Investing Activities
0.05-1.296.72-7.17-0.5----
Upgrade
Investing Cash Flow
0.020.030.653.29-5.25-1.44-0.130-0-0.03
Upgrade
Common Stock Issued
00007.291.554.410.090.110.1
Upgrade
Share Repurchases
0000-0.0800000
Upgrade
Other Financing Activities
0.10.392.46--0.15-0.11-0.080.02-0.15
Upgrade
Financing Cash Flow
0.10.392.4607.221.444.340.110.110.25
Upgrade
Net Cash Flow
0.01-1.270.610.51-1.13-1.973.35-0.01-0.070.03
Upgrade
Free Cash Flow
-0.11-1.68-2.49-2.85-3.31-2.92-0.99-0.12-0.18-0.23
Upgrade
Free Cash Flow Margin
-27.43%-5610.68%--39830.98%-33634.70%-30383.15%-17405.74%-106.76%--
Upgrade
Free Cash Flow Per Share
-0.01-1.37-2.16-2.54-3.00-2.91-1.08-0.14-0.22-0.27
Upgrade
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.